These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9776643)

  • 1. [The 3rd Japanese-United States Vancomycin Forum].
    Shimada K; Saito A; Yamaguchi K; Inamatsu T; Kobayashi Y; Oguma T; Kaatz GW; Rybak MJ; Boyce JM; Zeckel ML; Murao H
    Jpn J Antibiot; 1998 Jun; 51(6):363-94. PubMed ID: 9776643
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin use and antimicrobial resistance in hemodialysis centers.
    Tokars JI
    Am J Kidney Dis; 1998 Sep; 32(3):521-3. PubMed ID: 9740174
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin resistance in Staphylococcus aureus.
    John CC
    N Engl J Med; 1999 Jul; 341(3):207-8. PubMed ID: 10409039
    [No Abstract]   [Full Text] [Related]  

  • 4. New resistance in Staphylococcus aureus.
    Waldvogel FA
    N Engl J Med; 1999 Feb; 340(7):556-7. PubMed ID: 10021477
    [No Abstract]   [Full Text] [Related]  

  • 5. Vancomycin use in a hospital with vancomycin restriction.
    Roghmann MC; Perdue BE; Polish L
    Infect Control Hosp Epidemiol; 1999 Jan; 20(1):60-3. PubMed ID: 9927270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
    Sieradzki K; Roberts RB; Haber SW; Tomasz A
    N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward a post-antibiotic era?
    Bryan CS
    J S C Med Assoc; 1995 Jan; 91(1):35-7. PubMed ID: 7898059
    [No Abstract]   [Full Text] [Related]  

  • 8. First antibiotic in new class of drugs fights resistant infections.
    FDA Consum; 2000; 34(4):4. PubMed ID: 11924635
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complications in bone marrow transplantation. Resistant bacterial infections.
    Jacoby GA
    Recent Results Cancer Res; 1993; 132():241-7. PubMed ID: 8265866
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacteria are winning.
    Teuscher GW
    ASDC J Dent Child; 2001; 68(2):88. PubMed ID: 11475691
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.
    Tattevin P; Arvieux C; Michelet C
    Arch Intern Med; 2007 Jun; 167(11):1206; author reply 1208-9. PubMed ID: 17563033
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections.
    Howden BP; Johnson PD; Charles PG; Grayson ML
    Clin Infect Dis; 2004 Nov; 39(10):1544; author reply 1544-5. PubMed ID: 15546096
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing antibiotic use--impact of infection control.
    Wenzel RP; Wong MT
    Clin Infect Dis; 1999 May; 28(5):1126-7. PubMed ID: 10452646
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on emerging infections: news from the Centers for Disease Control and Prevention.
    Moran GJ; Mount J
    Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697
    [No Abstract]   [Full Text] [Related]  

  • 16. [New antibiotics for treatment of MRSA infections. Comparison of treatment with vancomycin].
    Burkhardt O; Derendorf H; Welte T
    Med Monatsschr Pharm; 2006 Feb; 29(2):56-62; quiz 63-4. PubMed ID: 16506589
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staph with lower vancomycin resistance in US.
    OR Manager; 1997 Oct; 13(10):7. PubMed ID: 10174189
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging antimicrobial-resistant infections.
    Roos KL
    Arch Neurol; 2004 Oct; 61(10):1512-4. PubMed ID: 15477503
    [No Abstract]   [Full Text] [Related]  

  • 20. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.